- Home
- PCYO vs SERA Comparison
PCYO vs SERA Comparison
Compare PCYO & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCYO
- SERA
- Stock Information
- Founded
- PCYO 1976
- SERA 2008
- Country
- PCYO United States
- SERA United States
- Employees
- PCYO N/A
- SERA N/A
- Industry
- PCYO Water Supply
- SERA Precision Instruments
- Sector
- PCYO Utilities
- SERA Health Care
- Exchange
- PCYO Nasdaq
- SERA Nasdaq
- Market Cap
- PCYO 248.0M
- SERA 70.4M
- IPO Year
- PCYO N/A
- SERA 2021
- Fundamental
- Price
- PCYO $10.69
- SERA $2.42
- Analyst Decision
- PCYO
- SERA
- Analyst Count
- PCYO 0
- SERA 0
- Target Price
- PCYO N/A
- SERA N/A
- AVG Volume (30 Days)
- PCYO 41.3K
- SERA 810.0K
- Earning Date
- PCYO 07-09-2025
- SERA 08-06-2025
- Dividend Yield
- PCYO N/A
- SERA N/A
- EPS Growth
- PCYO 118.08
- SERA N/A
- EPS
- PCYO 0.59
- SERA N/A
- Revenue
- PCYO $29,911,000.00
- SERA $115,000.00
- Revenue This Year
- PCYO N/A
- SERA $390.13
- Revenue Next Year
- PCYO N/A
- SERA $440.54
- P/E Ratio
- PCYO $18.84
- SERA N/A
- Revenue Growth
- PCYO 58.85
- SERA N/A
- 52 Week Low
- PCYO $9.17
- SERA $1.37
- 52 Week High
- PCYO $14.63
- SERA $9.13
- Technical
- Relative Strength Index (RSI)
- PCYO 53.11
- SERA 52.83
- Support Level
- PCYO $10.39
- SERA $1.82
- Resistance Level
- PCYO $11.16
- SERA $4.09
- Average True Range (ATR)
- PCYO 0.31
- SERA 0.35
- MACD
- PCYO 0.07
- SERA 0.08
- Stochastic Oscillator
- PCYO 59.48
- SERA 30.13
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.